Baker J A, Lant A F, Sutters C A
Riverside Health Authority, London.
BMJ. 1988 Aug 13;297(6646):465-9. doi: 10.1136/bmj.297.6646.465.
A study was carried out analysing the operation of a drug rationalisation programme in a central London teaching district that had evolved from experience over 17 years. Creation of a limited list of about 700 drugs had been achieved by local consensus. Drug selection was based on appraisal of efficacy, safety, and cost and was undertaken by means of collaborative participation of most consultant specialists in the district. Educative and other non-restrictive strategies for reinforcing the rationalisation policy had achieved a consistently high rate of compliance in prescribing recommended drugs. The concept of selectivity in drug use and its continuous local reappraisal had a beneficial impact on the prescribing habits of doctors at all levels of seniority as well as on the training of medical undergraduates and nurses in the therapeutic use of medicines. Peer review and self audit were encouraged by use of an extensive monitoring system which incorporated continuous "facilitative" dialogue between ward pharmacists and prescribers. Two models of drug rationalisation programme were studied, the second of which together with other local initiatives had been associated with substantial and sustained reductions in drug spending each year over nine years since 1978. It is concluded that the second drug rationalisation programme model substantially improves the cost effective use of drugs in hospital and furthermore has the potential of being extended to general practice, especially in types of prescribing that are common to both forms of patient care.
一项研究对伦敦市中心一个教学区实施了17年的药品合理化计划进行了分析。通过当地的共识,制定了一份约700种药品的有限清单。药品选择基于对疗效、安全性和成本的评估,由该地区大多数顾问专家共同参与进行。强化合理化政策的教育及其他非限制性策略在开具推荐药品方面取得了持续较高的合规率。药物使用的选择性概念及其持续的本地重新评估对各级资历医生的处方习惯以及医学本科生和护士在药物治疗使用方面的培训产生了有益影响。通过使用一个广泛的监测系统鼓励同行评审和自我审计,该系统纳入了病房药剂师和开处方者之间持续的“促进性”对话。研究了两种药品合理化计划模式,其中第二种模式与其他地方举措自1978年以来的九年里每年都使药品支出大幅且持续减少。得出的结论是,第二种药品合理化计划模式大幅提高了医院药品的成本效益使用,而且有可能扩展到全科医疗,特别是在两种患者护理形式中常见的处方类型方面。